Evidence map›Paper›PMID 11925595›Full record

ArticleWorld journal of gastroenterology2002

JTE-522-induced apoptosis in human gastric adenocarcinoma [correction of adenocarcinoma] cell line AGS cells by caspase activation accompanying cytochrome C release, membrane translocation of Bax and loss of mitochondrial membrane potential.

Hong-Liang Li, Dan-Dan Chen, Xiao-Hong Li, Hai-Wei Zhang, Jun-Hua Lü, Xian-Da Ren, Cun-Chuan Wang

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hong-Liang LiDepartment of Pharmacology, Jinan University Pharmacy College, Guangzhou 510632, Guangdong Province, China. tsam@jnu.edu.cn
Dan-Dan Chen
Xiao-Hong Li
Hai-Wei Zhang
Jun-Hua Lü
Xian-Da Ren
Cun-Chuan Wang
Jinan University · CNFirst Affiliated Hospital of Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the role of the mitochondrial pathway in JTE-522-induced apoptosis and to investigate the relationship between cytochrome C release, caspase activity and loss of mitochondrial membrane potential (Deltapsim).

methodsCell culture, cell counting, ELISA assay, TUNEL, flow cytometry, Western blot and fluorometric assay were employed to investigate the effect of JTE-522 on cell proliferation and apoptosis in AGS cells and related molecular mechanism.

resultsJTE-522 inhibited the growth of AGS cells and induced the apoptosis. Caspases 8 and 9 were activated during apoptosis as judged by the appearance of cleavage products from procaspase and the caspase activities to cleave specific fluorogenic substrates. To elucidate whether the activation of caspases 8 and 9 was required for the apoptosis induction, we examined the effect of caspase-specific inhibitors on apoptosis. The results showed that caspase inhibitors significantly inhibited the apoptosis induced by JTE-522. In addition, the membrane translocation of Bax and cytosolic release of cytochrome C accompanying with the decrease of the uptake of Rhodamin 123, were detected at an early stage of apoptosis. Furthermore, Bax translocation, cytochrome C release, and caspase 9 activation were blocked by Z-VAD.fmk and Z-IETD-CHO.

conclusionThe present data indicate a crucial association between activation of caspases 8, 9, cytochrome C release, membrane translocation of Bax, loss of Deltapsim and JTE-522-induced apoptosis in AGS cells.

Indexed as

AdenocarcinomaStomach NeoplasmsAmino Acid Chloromethyl KetonesAnti-Inflammatory Agents, Non-SteroidalApoptosisbcl-2-Associated X ProteinBenzenesulfonamidesBenzenesulfonatesCaspase InhibitorsCaspasesCyclooxygenase InhibitorsCysteine Proteinase InhibitorsCytochrome c GroupEnzyme ActivationHumansIn Situ Nick-End Labeling4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamideAmino Acid Chloromethyl KetonesAnti-Inflammatory Agents, Non-SteroidalBAX protein, humanbcl-2-Associated X ProteinBenzenesulfonamidesBenzenesulfonatesbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneCaspase InhibitorsCaspasesCyclooxygenase InhibitorsCysteine Proteinase InhibitorsCytochrome c GroupOxazolesProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID11925595
PMCPMC4658354
OpenAlexW2467104927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.